Chromothripsis in Treatment Resistance in Multiple Myeloma
Multiple myeloma (MM) is a malignant disease caused by an abnormal proliferation of plasma cells, of which the prognostic factors include chromosomal abnormality, β-2 microglobulin, and albumin. Recently, the term chromothripsis has emerged, which is the massive but highly localized chromosomal rear...
Saved in:
| Main Authors: | Kyoung Joo Lee, Ki Hong Lee, Kyong-Ah Yoon, Ji Yeon Sohn, Eunyoung Lee, Hyewon Lee, Hyeon-Seok Eom, Sun-Young Kong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2017-09-01
|
| Series: | Genomics & Informatics |
| Subjects: | |
| Online Access: | http://genominfo.org/upload/pdf/GI-2017-15-3-87.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chromothripsis in Oncology: Literature Review and Case Report
by: NN Mamaev, et al.
Published: (2017-04-01) -
The characteristics of Korean elderly multiple myeloma patients aged 80 years or over
by: Sang Hwan Lee, et al.
Published: (2025-01-01) -
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
by: Tobias S. Slørdahl, et al.
Published: (2025-02-01) -
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01) -
DIAGNOSTIC OF NONSECRETORY MULTIPLE MYELOMA (CLINICAL CASE)
by: N. T. Vatutin, et al.
Published: (2017-03-01)